Oxurion NV (OXUR.BR)

EUR 0.08

(-2.44%)

Operating Expenses Summary of Oxurion NV

  • Oxurion NV's latest annual operating expenses in 2023 was 12.21 Million EUR , down -46.3% from previous year.
  • Oxurion NV's latest quarterly operating expenses in 2024 Q2 was 2.28 Million EUR , down 0.0% from previous quarter.
  • Oxurion NV reported a annual operating expenses of 22.5 Million EUR in annual operating expenses 2022, down -21.1% from previous year.
  • Oxurion NV reported a annual operating expenses of 28.52 Million EUR in annual operating expenses 2021, down -5.46% from previous year.
  • Oxurion NV reported a quarterly operating expenses of 7.83 Million EUR for 2023 Q2, down 0.0% from previous quarter.
  • Oxurion NV reported a quarterly operating expenses of 5.06 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Operating Expenses Chart of Oxurion NV (2023 - 2006)

Historical Annual Operating Expenses of Oxurion NV (2023 - 2006)

Year Operating Expenses Operating Expenses Growth
2023 12.21 Million EUR -46.3%
2022 22.5 Million EUR -21.1%
2021 28.52 Million EUR -5.46%
2020 30.17 Million EUR -18.05%
2019 36.81 Million EUR -9.96%
2018 40.89 Million EUR 111.26%
2017 19.35 Million EUR -68.15%
2016 60.77 Million EUR 31.41%
2015 46.24 Million EUR -24.34%
2014 61.12 Million EUR -24.89%
2013 81.38 Million EUR 89.9%
2012 42.85 Million EUR 58.54%
2011 27.03 Million EUR 33.2%
2010 20.29 Million EUR 7.21%
2009 18.93 Million EUR 23.43%
2008 15.33 Million EUR -17.1%
2007 18.5 Million EUR 48.53%
2006 12.45 Million EUR 0.0%

Peer Operating Expenses Comparison of Oxurion NV

Name Operating Expenses Operating Expenses Difference
Nicox S.A. -11.5 Million EUR 206.181%
European Medical Solutions 13.64 Million EUR 10.5%
FERMENTALG 12.34 Million EUR 1.053%
argenx SE 1.34 Billion EUR 99.09%
BioSenic S.A. 7.58 Million EUR -61.071%
Celyad Oncology SA 8.49 Million EUR -43.863%
Hyloris Pharmaceuticals SA 17.98 Million EUR 32.095%
Onward Medical N.V. 20.64 Million EUR 40.838%
PHAXIAM Therapeutics S.A. 24.98 Million EUR 51.117%
Financière de Tubize SA 114.38 Thousand EUR -10577.6%
UCB SA 2.94 Billion EUR 99.585%